Focal Segmental Glomerulosclerosis
📧 Sign up to get email alerts when something new happens for Focal Segmental Glomerulosclerosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-06-25Clinical Trial Results: Obinutuzumab in Primary FSGS [Phase 2]
Phase 2 trial results evaluating obinutuzumab for primary focal segmental glomerulosclerosis have been completed and results posted.
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Genetic Markers for Focal Segmental Glomerulosclerosis
This clinical trial update reports on genetic markers linked to focal segmental glomerulosclerosis, including HIV-associated forms. The stud…
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: An Open-Label Phase 2 Study of N-Acetyl-D-Mannosamine (ManNAc) in Subjects With Primary Focal Segmental Glomerulosclerosis [Phase 2]
Open-label Phase 2 trial evaluating N-Acetyl-D-Mannosamine (ManNAc) in subjects with Primary Focal Segmental Glomerulosclerosis; currently r…
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: A Study of Praliciguat in Participants With Focal Segmental Glomerulosclerosis (FSGS) [Phase 2]
Phase 2 clinical trial of praliciguat in participants with focal segmental glomerulosclerosis is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: A Pilot Trial of taVNS for SRNS in Children (kidNEY-VNS) [NA]
A pilot trial evaluating transcutaneous auricular vagus nerve stimulation (taVNS) for steroid-resistant nephrotic syndrome in children is cu…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosclerosis (FSGS) [Phase 3]
A Phase 3 clinical trial evaluating BI 764198 in adults and adolescents with focal segmental glomerulosclerosis is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: taVNS for FRNS in Children [NA]
This clinical trial update notes that taVNS (transcutaneous auricular vagus nerve stimulation) is being studied for frequently relapsing nep…
-
CLINICAL_TRIALS research · 2026-04-09Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Frexalimab, Brivekimig, or Rilzabrutinib in Participants Aged 16 to 75 Years With Primary Focal Segmental Glomerulosclerosis or Minimal Change Disease [Phase 2]
Phase 2 clinical trial evaluating Frexalimab, Brivekimig, or Rilzabrutinib for primary focal segmental glomerulosclerosis or minimal change …
-
CLINICAL_TRIALS trial_result · 2026-04-08Clinical Trial Update: SLIT ABS: Study on Patients With Autoimmune Podocytopathy [NA]
This clinical trial update indicates the SLIT ABS study for autoimmune podocytopathy is currently recruiting, sponsored by Meyer Children's …
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: A Clinical Study of BAT4406F Injection in Patients With Minimal Change Disease/Focal Segmental Glomerulosclerosis [Phase 2, Phase 3]
A Phase 2/3 clinical trial assessing BAT4406F injection in adults with Minimal Change Disease and Focal Segmental Glomerulosclerosis is curr…
-
CLINICAL_TRIALS research · 2026-04-02Clinical Trial Update: Study of WAL0921 in Patients With Glomerular Kidney Diseases [Phase 2]
Walden Biosciences reports a Phase 2 clinical trial of WAL0921 in multiple glomerular diseases, currently recruiting.
-
CLINICAL_TRIALS trial_result · 2026-03-23Clinical Trial Update: Use of Acthar in Patients With FSGS That Will be Undergoing Renal Transplantation [Phase 3]
Phase 3 trial evaluating Acthar for focal segmental glomerulosclerosis in patients undergoing renal transplantation has completed with resul…
-
CLINICAL_TRIALS research · 2026-03-19Clinical Trial Update: A Study to Evaluate the Safety, Tolerability and PK of SK-09 [Phase 1]
A Phase 1 study is evaluating the safety, tolerability and pharmacokinetics of SK-09 for focal segmental glomerulosclerosis and minimal chan…
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: Sparsentan in Posttransplant Immunoglobulin A Nephropathy or Focal Segmental Glomerulosclerosis [Phase 4]
This clinical trial update indicates that sparsentan is being studied in Phase 4 for posttransplant immunoglobulin A nephropathy and focal s…
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: NEPTUNE Match Study [NA]
The NEPTUNE Match Study is currently recruiting, focusing on nephrotic syndrome in children and related glomerular diseases such as focal se…
-
CLINICAL_TRIALS research · 2026-02-03Clinical Trial Update: AMPK-activation by Metformin in FSGS: AMP-FSGS [Phase 1, Phase 2]
A Yale-sponsored clinical trial is investigating metformin to activate AMPK as a potential treatment for focal segmental glomerulosclerosis,…
-
CLINICAL_TRIALS research · 2026-02-03Clinical Trial Update: A Study of the Efficacy and Safety of DMX-200 in Patients With FSGS Who Are Receiving an ARB [Phase 3]
A Phase 3 study evaluating the efficacy and safety of DMX-200 in patients with focal segmental glomerulosclerosis who are on an ARB; the tri…
-
CLINICAL_TRIALS research · 2026-01-20Clinical Trial Update: Atacicept in Multiple Glomerular Diseases [Phase 2]
Phase 2 clinical trial evaluating atacicept in multiple glomerular diseases is currently recruiting, including primary membranous nephropath…
-
CLINICAL_TRIALS trial_result · 2026-01-12Clinical Trial Update: A Study to Test BI 764198 in People With a Type of Kidney Disease Called Focal Segmental Glomerulosclerosis [Phase 2]
Phase 2 study of BI-764198 in people with focal segmental glomerulosclerosis has completed with results posted.
-
CLINICAL_TRIALS research · 2025-12-23Clinical Trial Update: Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases [Phase 2]
Travere Therapeutics is running a phase 2 pediatric trial of sparsentan for proteinuric glomerular diseases, including Focal Segmental Glome…
-
CLINICAL_TRIALS research · 2025-12-22Clinical Trial Update: Interview Study of Adult and Child Patients and Parents of Children With Swelling Due to Nephrotic Syndrome.
This clinical trial update describes an interview study of adult and pediatric patients with swelling due to nephrotic syndrome and of paren…
-
CLINICAL_TRIALS research · 2025-10-09Clinical Trial Update: A Sequential Phase 2/3 Study of APL2 in Patients With Focal Segmental Glomerulosclerosis [Phase 2, Phase 3]
A sequential Phase 2/3 trial of APL2 is planned for focal segmental glomerulosclerosis and is currently not recruiting.
-
CLINICAL_TRIALS trial_result · 2025-09-29Clinical Trial Update: Study to Evaluate R3R01 in Patients With Alport Syndrome and Patients With Focal Segmental Glomerulosclerosis [Phase 2]
Phase 2 study evaluating R3R01 in patients with Alport syndrome and focal segmental glomerulosclerosis has completed.
-
CLINICAL_TRIALS research · 2025-09-17Clinical Trial Update: The FOrMe Registry (The German Focal Segmental Glomerulosclerosis and Minimal Change Disease Registry)
The FOrMe Registry is a Germany-based registry for focal segmental glomerulosclerosis and minimal change disease, currently recruiting to co…
-
CLINICAL_TRIALS research · 2025-09-17Clinical Trial Update: A Phase 1 Trial to Evaluate the Safety, Tolerability, Pharmacodynamics, Pharmacokinetics, and Immunogenicity of VIS171 in Participants With Autoimmune Disease(s) [Phase 1]
A Phase 1 clinical trial is evaluating the safety, tolerability, pharmacodynamics, pharmacokinetics, and immunogenicity of VIS171 in partici…